Bibliographic information
GuidelineConsolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
Year of Publication2016
Issuing InstitutionWHO
Recommendation
New
Oral PrEP (containing tenofovir disoproxil fumarate (TDF)) should be offered as an additional prevention choice for key populations at substantial risk of HIV infection as part of combination prevention approaches
Recommended in favor
Strong
Certainty of evidence
High